Middle East & Africa Diabetes Care Devices Market Size, Share & Trends Analysis Report By Type (BGM Devices, Insulin Delivery Devices), By Distribution Channel, By End-use (Hospitals, Homecare), And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Middle East & Africa Diabetes Care Devices Market Growth & Trends
The Middle East & Africa diabetes care devices market size is anticipated to reach USD 1.79 billion by 2030, growing at a CAGR of 8.20% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rapidly growing technological innovations and an increase in obesity prevalence primarily fuel the demand for diabetes care devices in the MEA. Furthermore, the increasing prevalence of diabetes, strategic initiatives such as collaborations and partnerships, and the rising use of insulin-delivery devices are boosting the market in the MEA. For instance, in December 2023, the International Diabetes Federation (IDF) and FIND joined to strengthen the expertise in continuous glucose monitoring (CGM) technology for healthcare professionals and diabetes patients. This partnership, known as ACCEDE (Improving CGM Access for Diabetes Equality), targets improving diabetes care through CGM usage in underprivileged nations, mainly focusing on Kenya and South Africa, which are low-income countries.
The growing awareness of diabetes care is driving the Middle East and Africa industry. With the rising prevalence of chronic diseases, the adoption of healthier lifestyles, and growing government initiatives, raises the demand, resulting in market expansion. For instance, in 2021, the UAE government has set a goal to improve its citizens' overall health and well-being, including reducing the prevalence of chronic diseases like diabetes. The National Agenda for UAE Vision 2021 includes strategies to enhance healthcare services, promote healthy lifestyles, and invest in research and innovation in the healthcare sector. These initiatives aim to reduce the burden of diabetes on the healthcare system and improve patients' overall quality of life.
Middle East & Africa Diabetes Care Devices Market Report Highlights
Middle East & Africa Diabetes Care Devices Market Growth & Trends
The Middle East & Africa diabetes care devices market size is anticipated to reach USD 1.79 billion by 2030, growing at a CAGR of 8.20% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rapidly growing technological innovations and an increase in obesity prevalence primarily fuel the demand for diabetes care devices in the MEA. Furthermore, the increasing prevalence of diabetes, strategic initiatives such as collaborations and partnerships, and the rising use of insulin-delivery devices are boosting the market in the MEA. For instance, in December 2023, the International Diabetes Federation (IDF) and FIND joined to strengthen the expertise in continuous glucose monitoring (CGM) technology for healthcare professionals and diabetes patients. This partnership, known as ACCEDE (Improving CGM Access for Diabetes Equality), targets improving diabetes care through CGM usage in underprivileged nations, mainly focusing on Kenya and South Africa, which are low-income countries.
The growing awareness of diabetes care is driving the Middle East and Africa industry. With the rising prevalence of chronic diseases, the adoption of healthier lifestyles, and growing government initiatives, raises the demand, resulting in market expansion. For instance, in 2021, the UAE government has set a goal to improve its citizens' overall health and well-being, including reducing the prevalence of chronic diseases like diabetes. The National Agenda for UAE Vision 2021 includes strategies to enhance healthcare services, promote healthy lifestyles, and invest in research and innovation in the healthcare sector. These initiatives aim to reduce the burden of diabetes on the healthcare system and improve patients' overall quality of life.
Middle East & Africa Diabetes Care Devices Market Report Highlights
- Based on type, the insulin delivery devices segment held the largest market share of 54.2% in 2023 and is expected to witness the fastest CAGR from 2024 to 2030. These devices are primarily used by individuals with diabetes who require insulin therapy to regulate their blood sugar. Insulin pens, pumps, needles, and syringes are the most widely used insulin delivery devices.
- Based on the distribution channel, the hospital pharmacies segment accounted for the largest revenue share in 2023. Hospital pharmacies stock various diabetes care devices, including blood glucose monitors, insulin delivery systems, and continuous glucose monitoring (CGM) systems.
- In terms of end-use, the hospital segment held the largest market revenue share in 2023. The hospital segment is expected to continue dominating the market due to the high foot traffic and availability of products, making it easier for patients to obtain diabetes care devices.
- This growth can be attributed to various market drivers, including technological advancements, increasing healthcare expenditure, and growing awareness about diabetes management.
- In October 2022, Nemaura Medical, Inc. received a tentative purchase order from TPMENA, their licensed company for the MENA region, for the sugarBEAT system. Nemaura Medical, Inc. is a medical technology firm dedicated to creating and marketing non-invasive wearable diagnostic devices, including CGM devices, and offering customized lifestyle coaching programs. The sugarBEAT system is an AI-powered CGM device.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Distribution channel
1.2.3. End-use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR's internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Distribution channel outlook
2.2.3. End-use outlook
2.3. Competitive Insights
CHAPTER 3. MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Middle East & Africa diabetes care devices Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Middle East & Africa Diabetes Care Devices Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Blood Glucose Monitoring Devices
4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million) (USD Million)
4.5.2. Self-Monitoring Devices
4.5.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.2.2. Blood glucose meters
4.5.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.2.3. Testing Strips
4.5.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.2.4. Lancets
4.5.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3. Continuous Glucose Monitoring Devices
4.5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.2. Sensors
4.5.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.3. Transmitters
4.5.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.4. Receiver
4.5.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.6. Insulin Delivery Devices
4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.6.2. Insulin Pens
4.6.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.6.3. Insulin Pumps
4.6.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.6.4. Insulin Syringes
4.6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.6.5. Insulin Jet injectors
4.6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
5.1. Distribution Channel Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Middle East & Africa Diabetes Care Devices Market by Distribution Channel Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Hospital pharmacies
5.4.1.1. Market estimates and forecast, 2018 - 2030 (USD Million) (USD Million)
5.4.2. Retail pharmacies
5.4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million) (USD Million)
5.4.3. Diabetes clinics/ centers
5.4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million) (USD Million)
5.4.4. Online pharmacies
5.4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million) (USD Million)
5.4.5. Others
5.4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Middle East & Africa Diabetes Care Devices Market by End-Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Hospitals
6.4.1.1. Market estimates and forecast, 2018 - 2030 (USD Million) (USD Million)
6.4.2. Diagnostic centers
6.4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million) (USD Million)
6.4.3. Homecare
6.4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million) (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company heat map analysis, 2023
7.4. Company Profiles
7.4.1. Abbott
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Dexcom, Inc.
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Medtronic
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. F. Hoffmann-La Roche Ltd
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Novo Nordisk A/S
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Ascensia Diabetes Care
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Bionime Corporation
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Agamatrix, Inc.
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Lifescan
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Insulet Corporation
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. Lilly
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives
7.4.12. Sanofi
7.4.12.1. Company overview
7.4.12.2. Financial performance
7.4.12.3. Product benchmarking
7.4.12.4. Strategic initiatives
7.4.13. Rossmax International Ltd.
7.4.13.1. Company overview
7.4.13.2. Financial performance
7.4.13.3. Product benchmarking
7.4.13.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. Distribution channel
1.2.3. End-use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR's internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Distribution channel outlook
2.2.3. End-use outlook
2.3. Competitive Insights
CHAPTER 3. MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Middle East & Africa diabetes care devices Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Middle East & Africa Diabetes Care Devices Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Blood Glucose Monitoring Devices
4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million) (USD Million)
4.5.2. Self-Monitoring Devices
4.5.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.2.2. Blood glucose meters
4.5.2.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.2.3. Testing Strips
4.5.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.2.4. Lancets
4.5.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3. Continuous Glucose Monitoring Devices
4.5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.2. Sensors
4.5.3.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.3. Transmitters
4.5.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.5.3.4. Receiver
4.5.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.6. Insulin Delivery Devices
4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.6.2. Insulin Pens
4.6.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.6.3. Insulin Pumps
4.6.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.6.4. Insulin Syringes
4.6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
4.6.5. Insulin Jet injectors
4.6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
5.1. Distribution Channel Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Middle East & Africa Diabetes Care Devices Market by Distribution Channel Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Hospital pharmacies
5.4.1.1. Market estimates and forecast, 2018 - 2030 (USD Million) (USD Million)
5.4.2. Retail pharmacies
5.4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million) (USD Million)
5.4.3. Diabetes clinics/ centers
5.4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million) (USD Million)
5.4.4. Online pharmacies
5.4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million) (USD Million)
5.4.5. Others
5.4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. End-use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Middle East & Africa Diabetes Care Devices Market by End-Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Hospitals
6.4.1.1. Market estimates and forecast, 2018 - 2030 (USD Million) (USD Million)
6.4.2. Diagnostic centers
6.4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million) (USD Million)
6.4.3. Homecare
6.4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million) (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company heat map analysis, 2023
7.4. Company Profiles
7.4.1. Abbott
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Product benchmarking
7.4.1.4. Strategic initiatives
7.4.2. Dexcom, Inc.
7.4.2.1. Company overview
7.4.2.2. Financial performance
7.4.2.3. Product benchmarking
7.4.2.4. Strategic initiatives
7.4.3. Medtronic
7.4.3.1. Company overview
7.4.3.2. Financial performance
7.4.3.3. Product benchmarking
7.4.3.4. Strategic initiatives
7.4.4. F. Hoffmann-La Roche Ltd
7.4.4.1. Company overview
7.4.4.2. Financial performance
7.4.4.3. Product benchmarking
7.4.4.4. Strategic initiatives
7.4.5. Novo Nordisk A/S
7.4.5.1. Company overview
7.4.5.2. Financial performance
7.4.5.3. Product benchmarking
7.4.5.4. Strategic initiatives
7.4.6. Ascensia Diabetes Care
7.4.6.1. Company overview
7.4.6.2. Financial performance
7.4.6.3. Product benchmarking
7.4.6.4. Strategic initiatives
7.4.7. Bionime Corporation
7.4.7.1. Company overview
7.4.7.2. Financial performance
7.4.7.3. Product benchmarking
7.4.7.4. Strategic initiatives
7.4.8. Agamatrix, Inc.
7.4.8.1. Company overview
7.4.8.2. Financial performance
7.4.8.3. Product benchmarking
7.4.8.4. Strategic initiatives
7.4.9. Lifescan
7.4.9.1. Company overview
7.4.9.2. Financial performance
7.4.9.3. Product benchmarking
7.4.9.4. Strategic initiatives
7.4.10. Insulet Corporation
7.4.10.1. Company overview
7.4.10.2. Financial performance
7.4.10.3. Product benchmarking
7.4.10.4. Strategic initiatives
7.4.11. Lilly
7.4.11.1. Company overview
7.4.11.2. Financial performance
7.4.11.3. Product benchmarking
7.4.11.4. Strategic initiatives
7.4.12. Sanofi
7.4.12.1. Company overview
7.4.12.2. Financial performance
7.4.12.3. Product benchmarking
7.4.12.4. Strategic initiatives
7.4.13. Rossmax International Ltd.
7.4.13.1. Company overview
7.4.13.2. Financial performance
7.4.13.3. Product benchmarking
7.4.13.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviations
Table 2 List of Secondary Sources
Table 3 Middle East & Africa diabetes care devices Market, By Region, 2018 - 2030 (USD Million)
Table 4 Middle East & Africa diabetes care devices Market, By Type, 2018 - 2030 (USD Million)
Table 5 Middle East & Africa diabetes care devices Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 6 Middle East & Africa diabetes care devices Market, By End-use, 2018 - 2030 (USD Million)
Table 7 South Africa diabetes care devices Market, By Type, 2018 - 2030 (USD Million)
Table 8 South Africa diabetes care devices Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 9 South Africa diabetes care devices Market, By End-use, 2018 - 2030 (USD Million)
Table 10 Saudi Arabia diabetes care devices Market, By Type, 2018 - 2030 (USD Million)
Table 11 Saudi Arabia diabetes care devices Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 12 Saudi Arabia diabetes care devices Market, By End-use, 2018 - 2030 (USD Million)
Table 13 UAE diabetes care devices Market, By Type, 2018 - 2030 (USD Million)
Table 14 UAE diabetes care devices Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 15 UAE diabetes care devices Market, By End-use, 2018 - 2030 (USD Million)
Table 16 Kuwait diabetes care devices Market, By Type, 2018 - 2030 (USD Million)
Table 17 Kuwait diabetes care devices Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 18 Kuwait diabetes care devices Market, By End-use, 2018 - 2030 (USD Million)
Table 1 List of abbreviations
Table 2 List of Secondary Sources
Table 3 Middle East & Africa diabetes care devices Market, By Region, 2018 - 2030 (USD Million)
Table 4 Middle East & Africa diabetes care devices Market, By Type, 2018 - 2030 (USD Million)
Table 5 Middle East & Africa diabetes care devices Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 6 Middle East & Africa diabetes care devices Market, By End-use, 2018 - 2030 (USD Million)
Table 7 South Africa diabetes care devices Market, By Type, 2018 - 2030 (USD Million)
Table 8 South Africa diabetes care devices Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 9 South Africa diabetes care devices Market, By End-use, 2018 - 2030 (USD Million)
Table 10 Saudi Arabia diabetes care devices Market, By Type, 2018 - 2030 (USD Million)
Table 11 Saudi Arabia diabetes care devices Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 12 Saudi Arabia diabetes care devices Market, By End-use, 2018 - 2030 (USD Million)
Table 13 UAE diabetes care devices Market, By Type, 2018 - 2030 (USD Million)
Table 14 UAE diabetes care devices Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 15 UAE diabetes care devices Market, By End-use, 2018 - 2030 (USD Million)
Table 16 Kuwait diabetes care devices Market, By Type, 2018 - 2030 (USD Million)
Table 17 Kuwait diabetes care devices Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 18 Kuwait diabetes care devices Market, By End-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Middle East & Africa diabetes care devices market: market outlook
Fig. 9 Middle East & Africa diabetes care devices competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Middle East & Africa diabetes care devices market driver impact
Fig. 14 Middle East & Africa diabetes care devices market restraint impact
Fig. 15 Middle East & Africa diabetes care devices market: Type movement analysis
Fig. 16 Middle East & Africa diabetes care devices market: Type outlook and key takeaways
Fig. 17 Blood glucose monitoring devices market estimates and forecast, 2018 - 2030
Fig. 18 Self-monitoring devices market estimates and forecast, 2018 - 2030
Fig. 19 Blood glucose meters market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Testing strips market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Lancets market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Continuous glucose monitoring devices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Sensor's market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Transmitters market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Receiver market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Insulin delivery devices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Insulin pumps market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Insulin pens market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Insulin syringes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Insulin jet injectors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Hospital pharmacies market estimates and forecasts, 2018 - 2030
Fig. 32 Diabetes Clinics/ Centers market estimates and forecasts, 2018 - 2030
Fig. 33 Online Pharmacies market estimates and forecasts, 2018 - 2030
Fig. 34 Other market estimates and forecasts, 2018 - 2030
Fig. 35 Hospital market estimates and forecasts, 2018 - 2030
Fig. 36 Diagnostic centers market estimates and forecasts, 2018 - 2030
Fig. 37 Homecare market estimates and forecasts, 2018 - 2030
Fig. 38 Middle East & Africa diabetes care devices market: Regional movement analysis
Fig. 39 Middle East & Africa diabetes care devices market: Regional outlook and key takeaways
Fig. 40 Middle East & Africa diabetes care devices market share and leading players
Fig. 41 MEA
Fig. 42 MEA market estimates and forecasts, 2018 - 2030
Fig. 43 South Africa
Fig. 44 South Africa market estimates and forecasts, 2018 - 2030
Fig. 45 Saudi Arabia
Fig. 46 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 47 UAE
Fig. 48 UAE market estimates and forecasts, 2018 - 2030
Fig. 49 Kuwait
Fig. 50 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Middle East & Africa diabetes care devices market: market outlook
Fig. 9 Middle East & Africa diabetes care devices competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Middle East & Africa diabetes care devices market driver impact
Fig. 14 Middle East & Africa diabetes care devices market restraint impact
Fig. 15 Middle East & Africa diabetes care devices market: Type movement analysis
Fig. 16 Middle East & Africa diabetes care devices market: Type outlook and key takeaways
Fig. 17 Blood glucose monitoring devices market estimates and forecast, 2018 - 2030
Fig. 18 Self-monitoring devices market estimates and forecast, 2018 - 2030
Fig. 19 Blood glucose meters market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Testing strips market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Lancets market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Continuous glucose monitoring devices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Sensor's market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Transmitters market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Receiver market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Insulin delivery devices market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Insulin pumps market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Insulin pens market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Insulin syringes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Insulin jet injectors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Hospital pharmacies market estimates and forecasts, 2018 - 2030
Fig. 32 Diabetes Clinics/ Centers market estimates and forecasts, 2018 - 2030
Fig. 33 Online Pharmacies market estimates and forecasts, 2018 - 2030
Fig. 34 Other market estimates and forecasts, 2018 - 2030
Fig. 35 Hospital market estimates and forecasts, 2018 - 2030
Fig. 36 Diagnostic centers market estimates and forecasts, 2018 - 2030
Fig. 37 Homecare market estimates and forecasts, 2018 - 2030
Fig. 38 Middle East & Africa diabetes care devices market: Regional movement analysis
Fig. 39 Middle East & Africa diabetes care devices market: Regional outlook and key takeaways
Fig. 40 Middle East & Africa diabetes care devices market share and leading players
Fig. 41 MEA
Fig. 42 MEA market estimates and forecasts, 2018 - 2030
Fig. 43 South Africa
Fig. 44 South Africa market estimates and forecasts, 2018 - 2030
Fig. 45 Saudi Arabia
Fig. 46 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 47 UAE
Fig. 48 UAE market estimates and forecasts, 2018 - 2030
Fig. 49 Kuwait
Fig. 50 Kuwait market estimates and forecasts, 2018 - 2030
